Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription Articles published in Exp Cell Res Retrieve available abstracts of 33 articles: HTML format Text format

Single Articles

July 2018
1. CHEN JH, Kuo KT, Bamodu OA, Lin YC, et al
   Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
   Exp Cell Res. 2018 Jul 4. pii: S0014-4827(18)30398.
   PubMed     Text format     Abstract available
   
   
   May 2018
2. DING J, Xu Z, Zhang Y, Tan C, et al
   Exosome-mediated miR-222 Transferring: An insight into NF-kappaB-mediated Breast Cancer Metastasis.
   Exp Cell Res. 2018 May 17. pii: S0014-4827(18)30276.
   PubMed     Text format     Abstract available
   
   
   April 2018
3. ROYSTON KJ, Paul B, Nozell S, Rajbhandari R, et al
   Withaferin A and Sulforaphane Regulate Breast Cancer Cell Cycle Progression through Epigenetic Mechanisms.
   Exp Cell Res. 2018 Apr 21. pii: S0014-4827(18)30226.
   PubMed     Text format     Abstract available
   
   
   March 2018
4. LI C, Fan Q, Quan H, Nie M, et al
   The three branches of the unfolded protein response exhibit differential significance in breast cancer growth and stemness.
   Exp Cell Res. 2018 Mar 27. pii: S0014-4827(18)30183.
   PubMed     Text format     Abstract available
   
   
   
5. LI K, Yan H, Guo W, Tang M, et al
   ATM inhibition induces synthetic lethality and enhances sensitivity of PTEN-deficient breast cancer cells to cisplatin.
   Exp Cell Res. 2018 Mar 6. pii: S0014-4827(18)30125.
   PubMed     Text format     Abstract available
   
   
   
6. YAMASHITA N, Saito N, Zhao S, Terai K, et al
   Heregulin-induced cell migration is promoted by aryl hydrocarbon receptor in HER2-overexpressing breast cancer cells.
   Exp Cell Res. 2018 Mar 1. pii: S0014-4827(18)30116.
   PubMed     Text format     Abstract available
   
   
   January 2018
7. MOREIRA MP, da Conceicao Braga L, Cassali GD, Silva LM, et al
   STAT3 as a promising chemoresistance biomarker associated with the CD44(+/high)/CD24(-/low)/ALDH(+) BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line.
   Exp Cell Res. 2018 Jan 15. pii: S0014-4827(18)30027.
   PubMed     Text format     Abstract available
   
   
   
8. HUANG Y, Yang L, Pei YY, Wang J, et al
   Overexpressed ACBD3 has prognostic value in human breast cancer and promotes the self-renewal potential of breast cancer cells by activating the Wnt/beta-catenin signaling pathway.
   Exp Cell Res. 2018 Jan 4. pii: S0014-4827(18)30003.
   PubMed     Text format     Abstract available
   
   
   
9. LUO CW, Wu CC, Chang SJ, Chang TM, et al
   CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
   Exp Cell Res. 2018 Jan 3. pii: S0014-4827(17)30695.
   PubMed     Text format     Abstract available
   
   
   December 2017
10. GONG XF, Yu AL, Tang J, Wang CL, et al
    MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
    Exp Cell Res. 2017 Dec 2. pii: S0014-4827(17)30640.
    PubMed     Text format     Abstract available
    
    
    November 2017
11. LO JH, Chen TT
    Production of bioactive recombinant human Eb-peptide of pro-IGF-I and identification of binding components from the plasma membrane of human breast cancer cells (MDA-MB-231).
    Exp Cell Res. 2017 Nov 27. pii: S0014-4827(17)30628.
    PubMed     Text format     Abstract available
    
    
    October 2017
12. ZHU S, Wang X, Wang J, Lin J, et al
    CD21lo/medCD27+ proinflammatory B cells are enriched in breast cancer patients and promote antitumor T cell responses.
    Exp Cell Res. 2017 Oct 17. pii: S0014-4827(17)30561.
    PubMed     Text format     Abstract available
    
    
    
13. DE S, Das S, Mukherjee S, Das S, et al
    Establishment of Twist-1 and TGFBR2 as direct targets of microRNA-20a in Mesenchymal to Epithelial Transition of Breast Cancer Cell-line MDA-MB-231.
    Exp Cell Res. 2017 Oct 4. pii: S0014-4827(17)30532.
    PubMed     Text format     Abstract available
    
    
    September 2017
14. CASCIONE M, De Matteis V, Toma CC, Pellegrino P, et al
    Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells.
    Exp Cell Res. 2017 Sep 19. pii: S0014-4827(17)30500.
    PubMed     Text format     Abstract available
    
    
    August 2017
15. HOU MF, Luo CW, Chang TM, Hung WC, et al
    The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
    Exp Cell Res. 2017 Aug 24. pii: S0014-4827(17)30450.
    PubMed     Text format     Abstract available
    
    
    
16. YAN N, Xu L, Wu X, Zhang L, et al
    GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Exp Cell Res. 2017 Aug 18. pii: S0014-4827(17)30435.
    PubMed     Text format     Abstract available
    
    
    
17. XIANG Y, Liao XH, Yao A, Qin H, et al
    MRTF-A-miR-206-WDR1 form feedback loop to regulate breast cancer cell migration.
    Exp Cell Res. 2017 Aug 17. pii: S0014-4827(17)30434.
    PubMed     Text format     Abstract available
    
    
    July 2017
18. TVEITARAS MK, Reigstad I, Leiss L, Reed RK, et al
    Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses.
    Exp Cell Res. 2017 Jul 19. pii: S0014-4827(17)30393.
    PubMed     Text format     Abstract available
    
    
    
19. SMUCZEK B, Santos ES, Siqueira AS, Pinheiro JJV, et al
    The laminin-derived peptide C16 regulates GPNMB expression and function in breast cancer.
    Exp Cell Res. 2017 Jul 5. pii: S0014-4827(17)30359.
    PubMed     Text format     Abstract available
    
    
    May 2017
20. YI Z, Yang D, Liao X, Guo F, et al
    PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer.
    Exp Cell Res. 2017 May 18. pii: S0014-4827(17)30296.
    PubMed     Text format     Abstract available
    
    
    
21. XIANG Y, Liao XH, Yu CX, Yao A, et al
    MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3.
    Exp Cell Res. 2017 May 9. pii: S0014-4827(17)30272.
    PubMed     Text format     Abstract available
    
    
    
22. XIE D, Liu Z, Wu J, Feng W, et al
    The effects of activin A on the migration of human breast cancer cells and neutrophils and their migratory interaction.
    Exp Cell Res. 2017 May 4. pii: S0014-4827(17)30267.
    PubMed     Text format     Abstract available
    
    
    
23. PERRI M, Caroleo MC, Liu N, Gallelli L, et al
    9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models.
    Exp Cell Res. 2017;354:25-30.
    PubMed     Text format     Abstract available
    
    
    March 2017
24. PATEL BB, Ackerstaff E, Serganova IS, Kerrigan JE, et al
    Tumor stroma interaction is mediated by monocarboxylate metabolism.
    Exp Cell Res. 2017;352:20-33.
    PubMed     Text format     Abstract available
    
    
    February 2017
25. GKRETSI V, Stylianou A, Stylianopoulos T
    Vasodilator-Stimulated Phosphoprotein (VASP) depletion from breast cancer MDA-MB-231 cells inhibits tumor spheroid invasion through downregulation of Migfilin, beta-catenin and urokinase-plasminogen activator (uPA).
    Exp Cell Res. 2017 Feb 13. pii: S0014-4827(17)30064.
    PubMed     Text format     Abstract available
    
    
    December 2016
26. DHO SH, Kim JY, Lee KP, Kwon ES, et al
    STAT5A-mediated NOX5-L expression promotes the proliferation and metastasis of breast cancer cells.
    Exp Cell Res. 2016 Dec 26. pii: S0014-4827(16)30434.
    PubMed     Text format     Abstract available
    
    
    
27. IRAVANI O, Bay BH, Yip GW
    Silencing HS6ST3 inhibits growth and progression of breast cancer cells through suppressing IGF1R and inducing XAF1.
    Exp Cell Res. 2016 Dec 23. pii: S0014-4827(16)30428.
    PubMed     Text format     Abstract available
    
    
    November 2016
28. CEPEDA MA, Pelling JJ, Evered CL, Leong HS, et al
    The cytoplasmic domain of MT1-MMP is dispensable for migration augmentation but necessary to mediate viability of MCF-7 breast cancer cells.
    Exp Cell Res. 2016 Nov 23. pii: S0014-4827(16)30391.
    PubMed     Text format     Abstract available
    
    
    September 2016
29. ALIMIRAH F, Peng X, Gupta A, Yuan L, et al
    Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
    Exp Cell Res. 2016 Sep 27. pii: S0014-4827(16)30243.
    PubMed     Text format     Abstract available
    
    
    August 2016
30. RADDE BN, Ivanova MM, Mai HX, Alizadeh-Rad N, et al
    Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells.
    Exp Cell Res. 2016 Aug 8. pii: S0014-4827(16)30235.
    PubMed     Text format     Abstract available
    
    
    July 2016
31. SENGUPTA D, Deb M, Rath SK, Kar S, et al
    DNA methylation and not H3K4trimethylation dictates the expression status of miR-152gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Exp Cell Res. 2016 Jul 27. pii: S0014-4827(16)30211.
    PubMed     Text format     Abstract available
    
    
    May 2016
32. DINICOLA S, Fabrizi G, Masiello MG, Proietti S, et al
    Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement.
    Exp Cell Res. 2016 May 26. pii: S0014-4827(16)30111.
    PubMed     Text format     Abstract available
    
    
    
33. DODDAPANENI R, Patel K, Chowdhury N, Singh M, et al
    Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
    Exp Cell Res. 2016 May 10. pii: S0014-4827(16)30110.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: